The effect of submaximal exercise on fibrinolysis

Blood Coagulation and Fibrinolysis

Volumn 15, Issue 3, 2004, Pages 227-234

  Fras, Ziatko ^a   Keber, Dušan ^a   Chandler, Wayne L ^b  

^a UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Fibrinolysis; Submaximal exercise; t PA clearance

Indexed keywords

ANTIGEN; INDOCYANINE GREEN; SODIUM CHLORIDE; TISSUE PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD ANALYSIS; BLOOD FLOW; CALCULATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EXERCISE; FIBRINOLYSIS; HUMAN; INFUSION; LIVER BLOOD FLOW; LIVER CLEARANCE; MALE; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; REST;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; EXERCISE; FEMALE; FIBRINOLYSIS; HUMANS; LIVER CIRCULATION; MALE; MIDDLE AGED; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 2342445740     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200404000-00005     Document Type: Article

References (36)

1. Hunter J. A. Treatise on blood, inflammation and gunshot wounds. London: G Nicol; 1794.
2. Biggs R, MacFarlane RG, Pilling J. Observations on fibrinolysis. Experimental activity produced by exercise or adrenaline. Lancet 1947; i: 402-405.
3. Molz AB, Heyduck B, Lill H, Spanuth E, Röcker L. The effect of different exercise intensities on the fibrinolytic system. Eur J Appl Physiol 1993; 67:298-304.
4. Röcker L, Taenzer M, Drygas WK, Lill H, Heyduck B, Altenkirch HU. Effect of prolonged physical exercise on the fibrinolytic system. Eur J Appl Physiol Occup Physiol 1990; 60:478-481.
5. Prowse CV, Cash JD. Physiologic and pharmacologic enhancement of fibrinolysis. Semin Thromb Hemostas 1984; 10:51-60.
6. Van Hinsbergh VWM. Regulation of the synthesis and secretion of plasminogen activators by endothelial cells. Haemostasis 1988; 18: 307-327.
7. de Boer A, Kluft C, Kroon JM, Kasper FJ, Schoemaker HC, Pruis J, et al. Liver blood flow as a major determinant of the clearance of recombinant human tissue-type plasminogen activator. Thromb Haemost 1992; 67:83-87.
8. Jorgensen M, Tonnesen KH, Petersen KR, Jespersen J, Gram J, Vinberg N. Splanchnic extraction and clearance of tissue plasminogen activator (t-PA) after injection of recombinant t-PA (Actilyse) in resting healthy subjects is proportional to the arterial concentration Blood Coagul Fibrinolysis 2002; 13:331-338.
9. Febbraio MA, Snow RJ, Hargreaves M, Stathis CG, Martin IK, Carey MF. Muscle metabolism during exercise and heat stress in trained men: effect of acclimation. J Appl Physiol 1994; 76:589-597.
10. Chandler WL, Veith RC, Fellingham GW, Levy WC, Schwartz RS, Cerqueira MD, et al. Fibrinolytic response during exercise and epinephrine infusion in the same subjects. J Am Coll Cardiol 1992; 19: 1412-1420.
11. Rowell LB, Blackmon JR, Bruce RA. Indocyanine green clearance and estimated hepatic blood flow during mild to maximal exercise in upright man. J Clin Invest 1964; 43:1677-1690.
12. Chandler WL, Levy WC, Veith RC, Stratton JR. A kinetic model of the circulatory regulation of tissue plasminogen activator during exercise, epinephrine infusion and endurance training. Blood 1993; 81: 3293-3302.
13. Chandler WL, Levy WC, Stratton JR. The circulatory regulation of TPA and UPA secretion, clearance, and inhibition during exercise and during the infusion of isoproterenol and phenylephrine. Circulation 1995; 92:2984-2994.
14. Baughman RA, Jr. Pharmacokinetics of tissue plasminogen activator. In: Sobel BE, Collen D, Grossbard EB (editors): Tissue plasminogen activator in thrombolytic therapy. New York: Marcel Dekker; 1987, pp. 41-53.
15. Nilsson T, Wallen P, Mellbring G. In vivo metabolism of human tissue-type plasminogen activator. Scand J Haematol 1984; 33:49-53.
16. Brommer EJP, Derkx FHM, Schalekamp MADH, Dooijewaard G. Renal and hepatic handling of endogenous tissue-type plasminogen activator (t-PA) and its inhibitor. Thromb Haemost 1988; 59:404-411.
17. George CF. Drug kinetics and hepatic blood flow. Clin Pharmacokinet 1979; 4:433-448.
18. Rowland M, Tozer TN. Clinical pharmacokinetics: concepts and applications. Philadelphia, PA: Lea & Febiger; 1989:63-77.
19. Caesar J, Shaldon S, Chiandussi L, Guevara L, Sherlock S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci 1961; 21:43-57.
20. Ranby M, Norman B, Wallen P. A sensitive assay for tissue plasminogen activator. Thromb Res 1982; 27:743-749.
21. Ranby M, Bergsdorf N, Nilsson T, Mellbring G, Winblad B, Bucht G. Age dependence of tissue plasminogen activator concentration in plasma, as studied by an improved enzyme-linked immunosorbent assay. Clin Chem 1986; 32:2160-2165.
22. Declerck PJ, Alessi MC, Verstreken M, Kruithof EKO, Juhan-Vague I, Collen D. Measurement of plasminogen activator inhibitor 1 in biologic fluids with a murine monoclonal antibody-based enzyme-linked immunosorbent assay. Blood 1988; 71:220-225.
23. Verheijen JH, Chang GTG, Kluft C. Evidence for the occurrence of fast acting inhibitor for tissue-type plasminogen activator in human plasma. Thromb Haemostas 1984; 51:392-395.
24. Friberger, Knos M. Plasminogen determination in human plasma. In: Scully M, Kakkar W (editors): Chromogenic peptide substrates. Edinburgh: Livingstone; 1979, pp. 128-139.
25. Friberger P. Method for the assay of antiplasmin in plasma. Scand J Lab Invest 1982; 42(suppl 16):41-47.
26. Clauss A. Gerinnungsphysiologische schnellmetode zur bestimmung des fibrinogens. Acta Haemat 1957; 17:237-246.
27. Keber D. On the use of different correction factors for hemoconcentration [Letter]. Thromb Haemost 1983; 49:245.
28. Grainger SL, Keeling PWN, Brown IMH, Marigold JH, Thompson RPH. Clearance and non-invasive determination of the hepatic extraction of indocyanine green in baboons and man. Clin Sci 1983; 64:207-212.
29. Mazzeo RS, Marshall P. Influence of plasma catecholamines on the lactate threshold during graded exercise. J Appl Physiol 1989; 67:1319-1322.
30. Hawkey C, Britton BJ, Wood WG, Peele M, Irving MH. Changes in blood catecholamine levels and blood coagulation and fibrinolytic activity in response to graded exercise in man. Br J Haematol 1975; 29:377-384.
31. Ferguson EW, Barr CF, Bernier LL. Fibrinogenolysis and fibrinolysis with strenuous exercise. J Appl Physiol 1979; 47:1157-1161.
32. Mohler MA, Refino CJ, Chen SA, Chen AB, Hotchkiss AJ. D-Phe-Pro-Arg-chloromethylketone: ist potential use in inhibiting the formation of in vitro artifacts in blood collected during tissue-type plasminogen activator thrombolytic therapy. Thromb Haemost 1986; 56:160-164.
33. Cadroy Y, Pillard F, Sakariasen KS, Thalamas C, Boneu B, Riviere D. Strenous but not moderate exercise increases thrombotic tendency in healthy sedentary male volunteers. J Appl Physiol 2002; 93:829-833.
34. Möckel M, Ulrich NV, Heller G Jr, Rocker L, Hansen R, Riess H, et al. Platelet activation through triathlon competition in ultra-endurance trained athletes: impact of thrombin and plasmin generation and catecholamine release. Int J Sports Med 2001; 22:337-343.
35. Van den Burg PJM, Hospers JEH, van Vliet M, Mosterd WL, Huisveld IA. Unbalanced haemostatic change following strenous physical exercise. A study in young sedentary males. Eur Heart J 1995; 16:1995-2001.
36. 2-adrenergic agonist-potentiated platelet activation. Arterioscler Thromb Vasc Biol 1999; 19:1559-1565.